Sleep Number (SNBR) News & Sentiment

SNBR's fourth-quarter 2024 results reflect soft market demand trends and benefits from a transformed operating model. Dive in to know more.

Sleep Number Corporation (NASDAQ:SNBR ) Q4 2024 Earnings Conference Call March 5, 2025 5:00 PM ET Company Participants Dave Schwantes - Vice President-Finance and Investor Relations Shelly Ibach - President and Chief Executive Officer Francis Lee - Chief Financial Officer Conference Call Participants Brad Thomas - KeyBanc Capital Markets Alessandra Jimenez - Raymond James Matthew Mccartney - Wedbush Securities Inc. Peter Keith - Piper Sandler Dan Silverstein - UBS Operator Welcome to Sleep Number's Q4 and Full Year 2024 Earnings Conference Call. [Operator Instructions] Today's call is being recorded.

Sleep Number (SNBR) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.58 per share a year ago.

Sleep Number (SNBR 2.06%), known for its customizable mattresses with integrated smart technology, released its fourth-quarter 2024 earnings on March 5, 2025. The company reported a notable improvement in earnings per share (EPS), with actual results showing a smaller loss of -$0.21 per share compared to forecasts of -$0.23.

MINNEAPOLIS--(BUSINESS WIRE)--Sleep Number Corporation Q4 and Full Year Earnings.

MINNEAPOLIS--(BUSINESS WIRE)--Today, Sleep Number Corporation (Nasdaq: SNBR) (“Sleep Number” or the “Company”) issued the following statement in response to the public letter to shareholders from Stadium Capital Management, LLC (together with its affiliates, “Stadium”): The Board of Directors (the “Board”) and leadership team of Sleep Number welcome shareholder input and suggestions. To that end, we have engaged extensively with Stadium and last November added two directors recommended by Stadi.

While the top- and bottom-line numbers for Sleep Number (SNBR) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Sleep Number (SNBR) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.10 per share a year ago.

Industry sales are expected to wobble for yet another year, but the improvements that SNBR has facilitated on the cost base could see it generate marginal EBITDA growth this year. Looking ahead, even if the topline growth ends up being anemic, EBITDA growth in FY25 and FY26 are poised to come in at double-digit growth levels. The stock is still priced at a discount on a forward EV/EBITDA basis, although that discount has come down from 30% in March to 12.5% currently.